Sanuwave Health, Inc. balance sheet
At the end of fiscal 2025, Sanuwave Health, Inc. had total assets of $37.3m, total liabilities of $35.7m and shareholders' equity of $1.6m. It held $12.0m in cash against $22.2m of debt: net debt of $10.3m.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 4 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 2 | 2 | 1 | 1 | 2 | 10 | 12 | 9 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 4 | 3 | 3 | 5 | 6 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 1 | 3 | 4 | 6 | 7 |
| Total current assets | 1 | 5 | 1 | 1 | 4 | 1 | 1 | 1 | 1 | 3 | 8 | 4 | 7 | 10 | 18 | 25 | 23 |
| Goodwill | — | — | — | — | — | — | — | — | — | 0 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Total assets | 3 | 6 | 2 | 2 | 5 | 1 | 1 | 1 | 1 | 3 | 23 | 19 | 20 | 22 | 30 | 37 | 37 |
| Accounts payable | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 1 | 4 | 8 | 4 | 6 | 4 | 3 | 3 |
| Deferred revenue (current) | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total current liabilities | 8 | 2 | 3 | 2 | 6 | 1 | 8 | 11 | 16 | 12 | 36 | 56 | 60 | 65 | 45 | 18 | 18 |
| Short-term debt | — | — | — | — | — | — | 0 | 0 | 2 | 0 | 17 | 25 | 14 | 18 | 25 | 6 | — |
| Long-term debt | — | — | 5 | — | — | — | 5 | — | — | 0 | 0 | 1 | — | — | — | 16 | — |
| Total debt | 0 | 0 | 5 | 2 | 0 | 0 | 5 | 0 | 2 | 1 | 32 | 26 | 22 | 7 | 0 | 22 | 13 |
| Total liabilities | 14 | 8 | 8 | 8 | 6 | 7 | 8 | 11 | 17 | 13 | 37 | 58 | 61 | 67 | 46 | 36 | 34 |
| Shareholders' equity | −11 | −2 | −7 | −6 | −2 | −6 | −7 | −10 | −15 | −10 | −14 | −39 | −41 | −45 | −16 | 2 | 3 |
| Net debt (negative = net cash) | −0 | −4 | 5 | 2 | −4 | −0 | 5 | −1 | 2 | −1 | 29 | 26 | 21 | 5 | −10 | 10 | 4 |
| Shares outstanding | — | 84m | 84m | 114m | 182m | 252m | 412m | 557m | 623m | 881m | 1,412m | 1,926m | 2,195m | 9m | 9m | 9m | 9m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 |
| Inventory | 3 | 4 | 5 | 6 | 7 | 6 | 6 | 7 |
| Total current assets | 10 | 18 | 19 | 20 | 23 | 25 | 24 | 23 |
| Goodwill | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Total assets | 22 | 30 | 31 | 33 | 36 | 37 | 37 | 37 |
| Accounts payable | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total current liabilities | 82 | 45 | 51 | 50 | 24 | 18 | 18 | 18 |
| Short-term debt | 24 | 25 | 26 | 27 | 6 | 6 | 6 | — |
| Long-term debt | — | — | — | — | 18 | 16 | 15 | — |
| Total debt | 24 | 25 | 26 | 27 | 23 | 22 | 21 | — |
| Total liabilities | 82 | 46 | 52 | 52 | 43 | 36 | 35 | 34 |
| Shareholders' equity | −60 | −16 | −21 | −19 | −8 | 2 | 2 | 3 |
| Shares outstanding | 3m | 9m | 9m | 9m | 9m | 9m | 9m | 9m |
Compare with peers
- Myomo, Inc. balance sheet
- Trisalus Life Sciences, Inc. balance sheet
- Koru Medical Systems, Inc. balance sheet
- Clearpoint Neuro, Inc. balance sheet
- Senseonics Holdings, Inc. balance sheet
Head to head: MYO vs SNWVSNWV vs TLSIKRMD vs SNWVCLPT vs SNWV
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies